XML 56 R46.htm IDEA: XBRL DOCUMENT v3.21.2
Intangible Assets (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2020
Sep. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2020
Acquired Indefinite-lived Intangible Assets [Line Items]              
Finite-Lived Intangible Assets, Net           $ 113,660
2018 Aspire Purchase Agreements [Member]              
Acquired Indefinite-lived Intangible Assets [Line Items]              
Finite-Lived Intangible Assets, Net             113,660
Finite-Lived Intangible Assets, Accumulated Amortization             $ 1,477,554
Glioblastoma Multiforme Brain Cancer [Member]              
Acquired Indefinite-lived Intangible Assets [Line Items]              
Asset Impairment Charges         $ 2,400,000    
Glioblastoma Multiforme Brain Cancer [Member] | Ovarian Cancer [Member]              
Acquired Indefinite-lived Intangible Assets [Line Items]              
Finite-lived Intangible Assets Acquired     13,300,000        
EGEN Inc [Member]              
Acquired Indefinite-lived Intangible Assets [Line Items]              
Asset Impairment Charges           $ 7,000,000  
Goodwill, Acquired During Period     2,000,000.0        
EGEN Inc [Member] | Purchase Agreement [Member]              
Acquired Indefinite-lived Intangible Assets [Line Items]              
Finite-lived Intangible Assets Acquired     $ 1,600,000        
Finite-Lived Intangible Asset, Useful Life     7 years        
Amortization       $ 56,830      
EGEN Inc [Member] | Glioblastoma Multiforme Brain Cancer [Member]              
Acquired Indefinite-lived Intangible Assets [Line Items]              
Asset Impairment Charges $ 2,400,000         $ 9,400,000  
[custom:NoncashCharge]   $ 2,400,000          
EGEN Inc [Member] | Glioblastoma Multiforme Brain Cancer [Member]              
Acquired Indefinite-lived Intangible Assets [Line Items]              
Indefinite-lived Intangible Assets Acquired     $ 24,200,000